Literature DB >> 1724659

Current management of homozygous beta thalassemia.

V P Choudhry1, N Desai, H P Pati, A Nanu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724659

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


× No keyword cloud information.
  7 in total

Review 1.  Oral deferiprone--controversies on its efficacy and safety.

Authors:  V P Choudhry
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

Review 2.  Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.

Authors:  V P Choudhry; S K Acharya
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

3.  Prevention of thalassemia: a necessity in India.

Authors:  I C Verma; V P Choudhry; P K Jain
Journal:  Indian J Pediatr       Date:  1992 Nov-Dec       Impact factor: 1.967

4.  Development of secondary sex characteristics in multitransfused thalassemic children.

Authors:  A George; A Bhaduri; V P Choudhry
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

5.  Physical growth parameters in thalassemic children.

Authors:  A George; A Bhaduri; S Sen; V P Choudhry
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

6.  Deferiprone, efficacy and safety.

Authors:  V P Choudhry; H P Pati; Anita Saxena; A N Malaviya
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

Review 7.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.